Federal Register / Vol. 74, No. 101 / Thursday, May 28, 2009 / Notices 25567 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Review of 

Competitive Revisions for Training Grant 

Applications Under the American Recovery 

and Reinvestment Act (ARRA). 

Date: June 10, 2009. 

Time: 8 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda North Marriott Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Jeannette F. Korczak, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, NIH, 6116 Executive Blvd., Room 

8115, Bethesda, MD 20892, 301–496–9767, 

korczakj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control; 93.701, ARRA Related 

Biomedical Research and Research Support 

Awards, National Institutes of Health, HHS) 

Dated: May 13, 2009. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E9–11820 Filed 5–27–09; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Capacity 

Building Assistance (CBA) To Improve 

the Delivery and Effectiveness of 

Human Immunodeficiency Virus (HIV) 

Prevention Services for High-Risk and/ 

or Racial/Ethnicity Minority 

Populations, Program Announcement 

Number PS09–906, Initial Review 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Times, Dates, and Panels: 

8:30 a.m.–5 p.m., June 15, 2009 (Closed). 

8:30 a.m.–5 p.m., June 16, 2009 (Closed). 

8:30 a.m.–5 p.m., June 17, 2009 (Closed). 

8:30 a.m.–12 p.m., June 18, 2009 (Closed). 

Place: W Hotel Atlanta–Midtown, 188 14th 

Street, NE., Atlanta, Georgia 30361, 

Telephone (404) 892–6000. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of ‘‘Capacity Building Assistance 

(CBA) To Improve the Delivery and 

Effectiveness of Human Immunodeficiency 

Virus (HIV) Prevention Services for HighRisk and/or Racial/Ethnicity Minority 

Populations, PS09–906.’’ 

Contact Person for More Information: 

Monica Farmer, M.Ed., Public Health 

Analyst, Strategic Science and Program Unit, 

Office of the Director, Coordinating Center 

for Infectious Diseases, CDC, 1600 Clifton 

Road, NE., Mailstop E–60, Atlanta, GA 

30333, Telephone: (404) 498–2277. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: May 19, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–12331 Filed 5–27–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Committee on Immunization 

Practices (ACIP) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 

8 a.m.–6 p.m., June 24, 2009. 

8 a.m.–5:45 p.m., June 25, 2009. 

8 a.m.–1 p.m., June 26, 2009. 

Place: CDC, Tom Harkin Global 

Communications Center, 1600 Clifton Road, 

NE., Building 19, Kent ‘‘Oz’’ Nelson 

Auditorium, Atlanta, Georgia 30333. 

Status: Open to the public, limited only by 

the space available. 

Purpose: The committee is charged with 

advising the Director, CDC, on the 

appropriate uses of immunizing agents. In 

addition, under 42 U.S.C. 1396s, the 

committee is mandated to establish and 

periodically review and, as appropriate, 

revise the list of vaccines for administration 

to vaccine-eligible children through the 

Vaccines for Children (VFC) program, along 

with schedules regarding the appropriate 

periodicity, dosage, and contraindications 

applicable to the vaccines. 

Matters To Be Discussed: The agenda will 

include discussions on General 

Recommendations; Rabies Vaccine; 

Poliovirus Vaccine; Measles, Mumps and 

Rubella Vaccine; Pneumococcal Vaccines; 

Yellow Fever Vaccine; Meningococcal 

Vaccine; Japanese Encephalitis; MMRV 

Vaccine Safety; Haemophilus influenzae b 

(Hib) Vaccine; Vaccine Supply; Hepatitis; 

Human Papillomavirus (HPV) Vaccines; 

Roles of Pharmacists in Vaccine 

Administration; Influenza Vaccines; and 

Novel Influenza A (H1N1). 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Antonette Hill, Immunization Services 

Division, National Center for Immunization 

and Respiratory Diseases, CDC, 1600 Clifton 

Road, NE., (E–05), Atlanta, Georgia 30333, 

telephone 404/639–8836, fax 404/639–8905. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities for 

both the CDC and Agency for Toxic 

Substances and Disease Registry. 

Dated: May 19, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–12334 Filed 5–27–09; 8:45 am] 

BILLING CODE 4160–18–P